Xinghao Wang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Systemic Lupus Erythematosus

Dendritic Cells

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xinghao Wang, Weiping Zou
Caught in the middle: MARCH5 mediates PD-1-induced IL-2R degradation. Cell research (2023)
Luz P Blanco, Eduardo Patino-Martinez, Shuichiro Nakabo, Mingzeng Zhang, Hege L Pedersen, Xinghao Wang, Carmelo Carmona-Rivera, Dillon Claybaugh, Zu-Xi Yu, Equar Desta, Mariana J Kaplan
Modulation of the Itaconate Pathway Attenuates Murine Lupus. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Kerry A Casey, Michael A Smith, Dominic Sinibaldi, Nickie L Seto, Martin P Playford, Xinghao Wang, Philip M Carlucci, Liangwei Wang, Gabor Illei, Binbing Yu, Shiliang Wang, Alan T Remaley, Nehal N Mehta, Mariana J Kaplan, Wendy I White
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 73 (3) (2021)
Luz P Blanco, Xinghao Wang, Philip M Carlucci, Jose Jiram Torres-Ruiz, Jorge Romo-Tena, Hong-Wei Sun, Markus Hafner, Mariana J Kaplan
RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells. Arthritis & rheumatology (Hoboken, N.J.) 73 (12) (2021)
Sarfaraz A Hasni, Sarthak Gupta, Michael Davis, Elaine Poncio, Yenealem Temesgen-Oyelakin, Philip M Carlucci, Xinghao Wang, Mohammad Naqi, Martin P Playford, Rishi Raj Goel, Xiaobai Li, Ann J Biehl, Isabel Ochoa-Navas, Zerai Manna, Yinghui Shi, Donald E Thomas, Jinguo Chen, Angélique Biancotto, Richard Apps, Foo Cheung, Yuri Kotliarov, Ashley L Babyak, Huizhi Zhou, Rongye Shi, Katie Stagliano, Wanxia Li Tsai, Laura Vian, Nathalia Gazaniga, Valentina Giudice, Shajia Lu, Stephen R Brooks, Meggan MacKay, Peter Gregersen, Nehal N Mehta, Alan T Remaley, Betty Diamond, John J O'Shea, Massimo Gadina, Mariana J Kaplan
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nature communications 12 (1) (2021)
Jeonghan Kim, Rajeev Gupta, Luz P Blanco, Shutong Yang, Anna Shteinfer-Kuzmine, Kening Wang, Jun Zhu, Hee Eun Yoon, Xinghao Wang, Martijn Kerkhofs, Hyeog Kang, Alexandra L Brown, Sung-Jun Park, Xihui Xu, Eddy D Zandee van Rilland, Myung K Kim, Jeffrey I Cohen, Mariana J Kaplan, Varda Shoshan-Barmaz, Jay H Chung
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science (New York, N.Y.) 366 (6472) (2019)